Mobileye Global Inc. (MBLY) cleared a low bar in the third quarter. Adjusted earnings of $0.11 per share topped both the $0.10 consensus and the $0.10 Earnings Whisper number by 10.0%, and rose 22.2% from a year ago. Revenue of $492.0 million beat the $473.84 million consensus by 3.8%, even though it fell 2.4% year over year. On a GAAP basis, the net loss narrowed to $(0.08) per share from $(0.12). Management also raised its full-year outlook for the third straight quarter. Look past the headline, though, and that is the central tension: much of the earnings improvement came from a government incentive, and most of the revenue upside came from business that earns little or no margin.
The quality of the beat deserves scrutiny. Adjusted operating income rose 20% to $89 million, and adjusted operating margin expanded to 18% from 15%. However, $51 million of that non-GAAP figure came from the incentive grant under Israel's new R&D Law. Strip it out and underlying adjusted operating income would have been roughly half of last year's $74 million. The release shows the pressure directly. Adjusted gross margin fell about 3 points to 64% because Chinese OEM export volumes carry less software content and lower EyeQ pricing. Average system price fell 5% from a year ago, though it ticked up sequentially to $49.1 from $48.5. GAAP gross margin did jump nearly 5 points to 53%, but that reflects lower intangible amortization, not better unit economics. The R&D credit is also non-cash for now: cash receipts for 2026 recognition are not expected until 2028. That helps explain why nine-month operating cash flow of $303 million trailed the prior year's $489 million.
The full-year raise follows the same pattern. The revenue midpoint moved up $13 million to about $2.008 billion, with the range narrowed to $1.995 billion to $2.020 billion, implying 5% to 7% growth. That continues a steady climb from roughly $1.94 billion originally. The adjusted operating income midpoint rose only to $400 million from $395 million, and it still embeds about $190 million of R&D Law benefit. Management was explicit about why so little of the extra revenue reaches the bottom line. The increase came mainly from stronger SuperVision deliveries, now expected near 65,000 units versus slightly below 60,000, plus roughly $7 million of zero-margin memory cost pass-through. Together those diluted corporate gross margin by about 100 basis points. The EyeQ volume outlook itself was unchanged. The guide also implies a soft fourth quarter: revenue of about $416 million (down roughly 8.5% sequentially), adjusted operating income near $60 million and 8.8 million to 8.9 million EyeQ units.
The call did preserve a credible longer-term content story. EyeQ shipments are on track for roughly 10% growth this year, even as production at Mobileye's top 10 customers declines about 5%. Two more automakers, a top-5 Asian OEM and a top-10 Japanese OEM, selected Cloud-Enhanced ADAS with REM. Stellantis expanded its program to European platforms, and three Surround ADAS customers are confirmed. Management laid out the pricing ladder for these products: Surround ADAS at about twice base ASP, SuperVision above $1,000 and Chauffeur near $2,500. It also guided 2027 EyeQ ASP roughly flat after a roughly $2 decline in 2026. On robotaxi, the plan firmed to 100 vehicles in the Orlando area in 2027, with Beep as the operations partner.
Bears have legitimate ammunition as well. Analysts pressed on reports that VW/Cariad selected a new autonomy partner. Management conceded that advanced-program nominations have been fewer, attributing this to a production-first focus, with business development expected to resume in 2027. Several costs remain open questions: memory inflation, ongoing 2027 pricing talks and unquantified robotaxi and Mentee spending. The CEO succession announced in Q2 is still pending. Cash and investments of $1.5 billion remain substantial, but they are down from year-end after the $591 million Mentee acquisition.
The market was clearly bracing for trouble. Investor sentiment swung from slightly positive at 0.048 to firmly negative at -0.45 heading into the report, a genuinely large deterioration. Shares at $7.06 are down 13.4% since the open after the July report and sit 17.8% below the 200-day moving average. They are 25% beneath the August high of $9.43, though 10.3% above the 52-week low of $6.40 set just days before earnings. Price and AVWAP trends remain negative, while momentum has turned positive off that low.
The bottom line is that Mobileye delivered a clean beat and another guidance raise against deeply pessimistic expectations. The underlying engine, however, looks flatter than the adjusted numbers suggest. The R&D credit, low-margin SuperVision volume and memory pass-through flattered the quarter, and the implied fourth-quarter step-down tempers the momentum. The design-win cadence and stabilizing 2027 ASP outlook give the bull case real substance. Still, investors will need to see content gains reach revenue and margins before the stock's downtrend has a strong fundamental reason to reverse.